Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Product: | Benzatropine Injection |
| Active Ingredient: | Benzatropine mesilate 1mg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Phebra NZ Limited |
| Manufacturer: | Phebra Pty Limited, Sydney, Australia |
| Product: | Capecitabine Mylan |
| Active Ingredient: | Capecitabine 150mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Mylan New Zealand Limited |
| Manufacturer: | Intas Pharmaceuticals Limited, Ahmedabad, India |
| Product: | Capecitabine Mylan |
| Active Ingredient: | Capecitabine 500mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Mylan New Zealand Limited |
| Manufacturer: | Intas Pharmaceuticals Limited, Ahmedabad, India |
| Product: | Teicoplanin Multichem |
| Active Ingredient: | Teicoplanin 400mg equivalent to NLT 400,000 IU. 10% overage included. |
| Dosage Form: | Powder for injection |
| New Zealand Sponsor: | Multichem NZ Limited |
| Manufacturer: | Demo SA Pharmaceutical Industry, Athens, Greece |
Dated this 27th day of September 2019.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).